ISSN 2756-3340
African Journal of Infectious Diseases Research | Vol. 12, No. 11, November 2025 | pp. 936–942
DOI: 10.46882/AJIDR/148897
Article Type: Research Article
Title: Antimicrobial susceptibility and beta-lactamase gene profiles of Stenotrophomonas maltophilia isolated from hospitalized immunocompromised patients
Names of Authors: Youssef Mansour¹*, Katrin Weber², Mei-Ling Chen³
Authors’ Affiliations: ¹Department of Clinical Pathology, Cairo University, Cairo, Egypt. ²Department of Medical Microbiology, Heidelberg University, Heidelberg, Germany. ³Department of Laboratory Medicine, National Taiwan University, Taipei, Taiwan.
Abstract: Stenotrophomonas maltophilia is an emerging multidrug-resistant non-fermenting Gram-negative bacillus causing severe nosocomial pneumonia and bacteremia in debilitated hosts. We evaluated antimicrobial susceptibility patterns and sul1 and dfrA resistance determinants among clinical S. maltophilia isolates. A total of 110 non-duplicate isolates from respiratory and bloodstream specimens underwent broth microdilution testing and polymerase chain reaction assays. Trimethoprim-sulfamethoxazole and levofloxacin demonstrated 88.2 percent and 84.5 percent susceptibility, respectively, whereas intrinsic resistance to carbapenems and aminoglycosides was universal. Restricting unnecessary carbapenem exposure is critical to prevent selection pressure.
Keywords: Stenotrophomonas maltophilia, Nosocomial infection, Multidrug resistance, Trimethoprim-sulfamethoxazole, Antimicrobial stewardship
Citation: Mansour Y, Weber K, Chen M (2025). Antimicrobial susceptibility and beta-lactamase gene profiles of Stenotrophomonas maltophilia isolated from hospitalized immunocompromised patients. African Journal of Infectious Diseases Research, 12(11): 936–942. DOI: 10.46882/AJIDR/148897
Manuscript Timeline: Received: October 01, 2025; Revised: November 01, 2025; Accepted: November 14, 2025; Published: November 21, 2025
Subscribe to read the full article: https://mail.internationalscholarsjournals.org/subscribe-to-read